The probiotic vsl#3® does not seem to be efficacious for the treatment of gastrointestinal symptomatology of patients with fibromyalgia: A randomized, double-blind, placebo-controlled clinical trial
- Calandre, E.P.
- Hidalgo-Tallon, J.
- Molina-Barea, R.
- Rico-Villademoros, F.
- Molina-Hidalgo, C.
- Garcia-Leiva, J.M.
- Carrillo-Izquierdo, M.D.
- Slim, M.
Journal:
Pharmaceuticals
ISSN: 1424-8247
Year of publication: 2021
Volume: 14
Issue: 10
Type: Article